Evidence map›Paper›PMID 20668910›Full record

ReviewCellular and molecular life sciences : CMLS2010

RhoA/Rho-kinase and vascular diseases: what is the link?

Kenia Pedrosa Nunes, Christine S Rigsby, R Clinton Webb

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 151 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Pharmacotherapy in SAH: Clinical Trial Lessons.CNS & neurological disorders drug targets · 2024
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kenia Pedrosa NunesDepartment of Physiology, Medical College of Georgia, Augusta, GA 30912, USA. knunes@mcg.edu
Christine S Rigsby
R Clinton Webb
Augusta University · US

Funding

Nitric Oxide Inhibits RhoA/Rho-kinase in Penile ErectionR01HL071138 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI WEBB, R CLINTON · 2003 to 2011
$2.9M
TNF-alpha: a key player in erectile (dys)functionR01DK083685 · NIDDK · AUGUSTA UNIVERSITY · PI WEBB, R CLINTON · 2009 to 2012
$1.4M
NHLBI NIH HHS R01 HL071138NIDDK NIH HHS R01 DK083685
6 · The paper itself

Abstract

RhoA/Rho-kinase pathway plays an important role in many pathological conditions. RhoA participates in the regulation of smooth muscle tone and activates many downstream kinases. The best characterized are the serine/threonine kinase isoforms (Rho-kinase or ROCK), ROCKα/ROCK2 and ROCKβ/ROCK1. ROCK is necessary for diverse functions such as local blood flow, arterial/pulmonary blood pressure, airway resistance and intestinal peristalsis. ROCK activation permits actin/myosin interactions and smooth muscle cells contraction by maintaining the activity of myosin light-chain kinase, independently of the free cytosolic calcium level. The sensitization of smooth muscle myofilaments to calcium has been implicated in many pathological states, such as hypertension, diabetes, heart attack, stroke, pulmonary hypertension, erectile dysfunction, and cancer. The focus of this review is on the involvement of RhoA/Rho-kinase in diseases. We will briefly describe the ROCK isoforms and the role of RhoA/Rho-kinase in the vasculature, before exploring the most recent findings regarding this pathway and various diseases.

Indexed as

AnimalsCardiovascular DiseasesDiabetes MellitusErectile DysfunctionHumansHypertension, PulmonaryMaleNeoplasmsrho-Associated Kinasesrho-Associated Kinases

Identifiers

PMID20668910
PMCPMC2996825
OpenAlexW1963620624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.